+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Italy Veterinary Healthcare Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 5120197
  • Report
  • June 2020
  • Region: Italy
  • 111 Pages
  • Mordor Intelligence

FEATURED COMPANIES

  • Candioli Pharma
  • Dox-al Italia S.p.A
  • FATRO S.p.A.
  • Friulchem
  • LIVISTO company
  • Teknofarma S.p.A.
Rising adoption of the pet animals is the major driving factor for the growth of Italy veterinary Healthcare Market. As per the estimates of the European Pet Food Industry in Italy there were around 6,970,000 dogs and 7,480,000 cats. Furthermore, there is also an increasing use of animals for various research studies in Italy. According to the latest figures, Italy conducted 611,707 procedures on animals in 2016, a 4.3% increase from 2015. The increase in the prevalence of various animal diseases in Italy is expected to create huge demand for the veterinary healthcare market in Italy. Also, there are few organizations creating awareness about various diseases in animals. For instance, ESCCAP in Italy brings together some of Italy's leading experts in the field of veterinary parasitology. It aims to raise awareness and recommendation of appropriate and proven control measures to protect companion animals. However, lack of veterinarians and high cost associated with the veterinary healthcare practice are the major factors restraining the growth of veterinary healthcare market in Italy.

Key Market Trends

Vaccines to dominate the Italy Veterinary Healthcare Market

The incidence of new infections that provide an opportunity to develop new vaccines and the increased government programs are expected to propel the growth of the veterinary vaccines market in Italy, during the forecast period. The Italian Ministry of Health (MOH) is the central body that deals with orientation and planning on issues related to veterinary health, food hygiene, and safety. In 2013, vaccination for Sylvatic rabies became voluntary and compulsory for the dogs. Long-lasting vaccines were highly preferred, during mass vaccination. Six variants of bluetongue virus were identified in Italy, and the unavailability of polyvalent vaccines led to the challenge of predicting its usage.

In addition, increased usage of vaccines among livestock as well as companion animals boost the demand for the product. Epidemics over previous years have caused significant losses in the animal breeding industry, propelling demand for vaccinations. In addition, consistent number of mergers and acquisitions undertaken by key market players to expand vaccines portfolio is expected to expand the growth potential to a significant level. For instance, in January 2018, Elanco acquired Boehringer Ingelheim Vetmedica’s U.S. Canine, Feline, and Rabies vaccines product portfolio in order to expand its business.

Competitive Landscape

The Italy Veterinary Healthcare market has rapidly evolved over the past decade. The industry has observed drastic changes in adopting market strategies such as product developments, mergers, and acquisitions in recent years. Thus, the Italy Veterinary Healthcare market has become a very competitive industry.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Candioli Pharma
  • Dox-al Italia S.p.A
  • FATRO S.p.A.
  • Friulchem
  • LIVISTO company
  • Teknofarma S.p.A.

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Advanced Technology Leading to Innovations in Animal Healthcare
4.2.2 Increasing Pet Ownership
4.3 Market Restraints
4.3.1 Lack of Veterinarians and Shortage of Skilled Farm Workers
4.3.2 Increasing Cost of Animal Testing and Veterinary Services
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 By Therapeutics
5.1.1.1 Vaccines
5.1.1.2 Parasiticides
5.1.1.3 Anti-infectives
5.1.1.4 Medical Feed Additives
5.1.1.5 Other Therapeutics
5.1.2 By Diagnostics
5.1.2.1 Immunodiagnostic Tests
5.1.2.2 Molecular Diagnostics
5.1.2.3 Diagnostic Imaging
5.1.2.4 Clinical Chemistry
5.1.2.5 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs and Cats
5.2.2 Horses
5.2.3 Ruminants
5.2.4 Swine
5.2.5 Poultry
5.2.6 Other Animals
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Zoetis Inc.
6.1.2 Virbac
6.1.3 scil animal care company S.r.l.
6.1.4 FATRO S.p.A.
6.1.5 LIVISTO company
6.1.6 Candioli Pharma
6.1.7 Teknofarma S.p.A.
6.1.8 Dox-al Italia S.p.A
6.1.9 Friulchem
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Zoetis Inc.
  • Virbac
  • scil animal care company S.r.l.
  • FATRO S.p.A.
  • LIVISTO company
  • Candioli Pharma
  • Teknofarma S.p.A.
  • Dox-al Italia S.p.A
  • Friulchem
Note: Product cover images may vary from those shown

Loading
LOADING...